These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

311 related items for PubMed ID: 9557822

  • 1. Somatotropic axis and body weight in pre-menopausal and post-menopausal women: evidence for a neuroendocrine derangement, in absence of changes of insulin-like growth factor binding protein concentrations.
    Bernardi F, Petraglia F, Seppala M, Spinetti A, Bertolini S, Ferdeghini M, Genazzani AR.
    Hum Reprod; 1998 Feb; 13(2):279-84. PubMed ID: 9557822
    [Abstract] [Full Text] [Related]

  • 2. Endocrine and metabolic effects of long-term administration of [Nle27]growth hormone-releasing hormone-(1-29)-NH2 in age-advanced men and women.
    Khorram O, Laughlin GA, Yen SS.
    J Clin Endocrinol Metab; 1997 May; 82(5):1472-9. PubMed ID: 9141536
    [Abstract] [Full Text] [Related]

  • 3. GH, IGFBP-1, and IGFBP-3 response to oral glucose tolerance test in perimenopausal women: no influence of body mass index.
    Bernardi F, Petraglia F, Seppälä M, Spinetti A, Bertolini S, Driul L, Ferdeghini M, Genazzani AR.
    Maturitas; 1999 Oct 24; 33(2):163-9. PubMed ID: 10597881
    [Abstract] [Full Text] [Related]

  • 4. Effect of menopause and different combined estradiol-progestin regimens on basal and growth hormone-releasing hormone-stimulated serum growth hormone, insulin-like growth factor-1, insulin-like growth factor binding protein (IGFBP)-1, and IGFBP-3 levels.
    Cano A, Castelo-Branco C, Tarín JJ.
    Fertil Steril; 1999 Feb 24; 71(2):261-7. PubMed ID: 9988395
    [Abstract] [Full Text] [Related]

  • 5. Sustained elevation of pulsatile growth hormone (GH) secretion and insulin-like growth factor I (IGF-I), IGF-binding protein-3 (IGFBP-3), and IGFBP-5 concentrations during 30-day continuous subcutaneous infusion of GH-releasing peptide-2 in older men and women.
    Bowers CY, Granda R, Mohan S, Kuipers J, Baylink D, Veldhuis JD.
    J Clin Endocrinol Metab; 2004 May 24; 89(5):2290-300. PubMed ID: 15126555
    [Abstract] [Full Text] [Related]

  • 6. Influence of chronic Naltrexone treatment on growth hormone and insulin secretion in obese subjects.
    De Marinis L, Mancini A, Valle D, Bianchi A, De Luca AM, Fulghesu AM, Villa P, Mancuso S, Lanzone A.
    Int J Obes Relat Metab Disord; 1997 Nov 24; 21(11):1076-81. PubMed ID: 9368834
    [Abstract] [Full Text] [Related]

  • 7. Circulating levels of free insulin-like growth factors in obese subjects: the impact of type 2 diabetes.
    Frystyk J, Skjaerbaek C, Vestbo E, Fisker S, Orskov H.
    Diabetes Metab Res Rev; 1999 Nov 24; 15(5):314-22. PubMed ID: 10585616
    [Abstract] [Full Text] [Related]

  • 8. Insulin, somatotropic, and luteinizing hormone axes in lean and obese women with polycystic ovary syndrome: common and distinct features.
    Morales AJ, Laughlin GA, Bützow T, Maheshwari H, Baumann G, Yen SS.
    J Clin Endocrinol Metab; 1996 Aug 24; 81(8):2854-64. PubMed ID: 8768842
    [Abstract] [Full Text] [Related]

  • 9. Effect of severe growth hormone (GH) deficiency due to a mutation in the GH-releasing hormone receptor on insulin-like growth factors (IGFs), IGF-binding proteins, and ternary complex formation throughout life.
    Aguiar-Oliveira MH, Gill MS, de A Barretto ES, Alcântara MR, Miraki-Moud F, Menezes CA, Souza AH, Martinelli CE, Pereira FA, Salvatori R, Levine MA, Shalet SM, Camacho-Hubner C, Clayton PE.
    J Clin Endocrinol Metab; 1999 Nov 24; 84(11):4118-26. PubMed ID: 10566659
    [Abstract] [Full Text] [Related]

  • 10. Evidence for integrity of the growth hormone/insulin-like growth factor-1 axis in patients with severe head trauma during rehabilitation.
    Bondanelli M, Ambrosio MR, Margutti A, Boldrini P, Basaglia N, Franceschetti P, Zatelli MC, Degli Uberti EC.
    Metabolism; 2002 Oct 24; 51(10):1363-9. PubMed ID: 12370860
    [Abstract] [Full Text] [Related]

  • 11. Growth hormone secretion and leptin in morbid obesity before and after biliopancreatic diversion: relationships with insulin and body composition.
    De Marinis L, Bianchi A, Mancini A, Gentilella R, Perrelli M, Giampietro A, Porcelli T, Tilaro L, Fusco A, Valle D, Tacchino RM.
    J Clin Endocrinol Metab; 2004 Jan 24; 89(1):174-80. PubMed ID: 14715846
    [Abstract] [Full Text] [Related]

  • 12. No evidence of insulin-like growth factor-binding protein 3 proteolysis during a maximal exercise test in elite athletes.
    Dall R, Lange KH, Kjaer M, Jørgensen JO, Christiansen JS, Orskov H, Flyvbjerg A.
    J Clin Endocrinol Metab; 2001 Feb 24; 86(2):669-74. PubMed ID: 11158029
    [Abstract] [Full Text] [Related]

  • 13. Changes in total ghrelin within the somatotropic axis in severe burn patients: comparison of those with inhalation injury and those without inhalation injury.
    Lee BW, Park SH, Ihm SH, Kim JH, Kim DH, You KC, Kim SW, Yoo HJ.
    Growth Horm IGF Res; 2008 Aug 24; 18(4):291-7. PubMed ID: 18178497
    [Abstract] [Full Text] [Related]

  • 14. Changes in serum concentrations of growth hormone, insulin, insulin-like growth factor and insulin-like growth factor-binding proteins 1 and 3 and urinary growth hormone excretion during the menstrual cycle.
    Juul A, Scheike T, Pedersen AT, Main KM, Andersson AM, Pedersen LM, Skakkebaek NE.
    Hum Reprod; 1997 Oct 24; 12(10):2123-8. PubMed ID: 9402266
    [Abstract] [Full Text] [Related]

  • 15. Effects of recombinant human insulin-like growth factor I administration on spontaneous and growth hormone (GH)-releasing hormone-stimulated GH secretion in anorexia nervosa.
    Gianotti L, Pincelli AI, Scacchi M, Rolla M, Bellitti D, Arvat E, Lanfranco F, Torsello A, Ghigo E, Cavagnini F, Müller EE.
    J Clin Endocrinol Metab; 2000 Aug 24; 85(8):2805-9. PubMed ID: 10946886
    [Abstract] [Full Text] [Related]

  • 16. Effect of obesity on total and free insulin-like growth factor (IGF)-1, and their relationship to IGF-binding protein (BP)-1, IGFBP-2, IGFBP-3, insulin, and growth hormone.
    Nam SY, Lee EJ, Kim KR, Cha BS, Song YD, Lim SK, Lee HC, Huh KB.
    Int J Obes Relat Metab Disord; 1997 May 24; 21(5):355-9. PubMed ID: 9152736
    [Abstract] [Full Text] [Related]

  • 17. Preservation of GHRH and GH-releasing peptide-2 efficacy in young men with experimentally induced hypogonadism.
    Veldhuis JD, Keenan DM, Bailey JN, Miles JM, Bowers CY.
    Eur J Endocrinol; 2009 Aug 24; 161(2):293-300. PubMed ID: 19458139
    [Abstract] [Full Text] [Related]

  • 18. Growth hormone in obesity.
    Scacchi M, Pincelli AI, Cavagnini F.
    Int J Obes Relat Metab Disord; 1999 Mar 24; 23(3):260-71. PubMed ID: 10193871
    [Abstract] [Full Text] [Related]

  • 19. Interactions among pro-inflammatory cytokines, IGF system and thyroid function in pre-pubertal obese subjects.
    Street ME, Smerieri A, Montanini L, Predieri B, Iughetti L, Valenzise M, De Luca F, Vigone M, Weber G, Maghnie M, Bernasconi S.
    J Biol Regul Homeost Agents; 2013 Mar 24; 27(1):259-66. PubMed ID: 23489706
    [Abstract] [Full Text] [Related]

  • 20. Effects of short-term treatment with orlistat on growth hormone/insulin-like growth factor-I axis in obese post-menopausal women.
    Di Somma C, Rivellese A, Pizza G, Patti L, De Rosa A, Cipriano P, Nedi V, Rossi A, Lombardi G, Colao A, Savastano S.
    J Endocrinol Invest; 2011 Feb 24; 34(2):90-6. PubMed ID: 21502796
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.